Everolimus Novartis 0,25 mg Dispergerbar tablett

Pays: Suède

Langue: suédois

Source: Läkemedelsverket (Medical Products Agency)

Ingrédients actifs:

everolimus

Disponible depuis:

Novartis Sverige AB

Code ATC:

L04AH02

DCI (Dénomination commune internationale):

everolimus

Dosage:

0,25 mg

forme pharmaceutique:

Dispergerbar tablett

Composition:

laktos (vattenfri) Hjälpämne; laktosmonohydrat Hjälpämne; butylhydroxitoluen Hjälpämne; everolimus 0,25 mg Aktiv substans

classe:

Apotek

Type d'ordonnance:

Receptbelagt

Domaine thérapeutique:

Everolimus

Statut de autorisation:

Avregistrerad

Date de l'autorisation:

2003-08-08

Notice patient

1
PACKAGE LEAFLET: INFORMATION FOR THE USER
EVEROLIMUS NOVARTIS 0.1 MG DISPERSIBLE TABLETS
EVEROLIMUS NOVARTIS 0.25 MG DISPERSIBLE TABLETS
Everolimus
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Everolimus Novartis is and what it is used for
2.
What you need to know before you take Everolimus Novartis
3.
How to take Everolimus Novartis
4.
Possible side effects
5.
How to store Everolimus Novartis
6.
Contents of the pack and other information
1.
WHAT EVEROLIMUS NOVARTIS IS AND WHAT IT IS USED FOR
The active substance of Everolimus Novartis is everolimus.
Everolimus belongs to a group of medicines called immunosuppressants.
It is used in adults to prevent
the body’s immune system from rejecting a transplanted kidney, heart
or liver.
Everolimus Novartis is used together with other medicines, such as
ciclosporin for kidney and heart
transplantation, tacrolimus for liver transplantation, and
corticosteroids.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE EVEROLIMUS NOVARTIS
DO NOT TAKE EVEROLIMUS NOVARTIS

if you are allergic (hypersensitive) to everolimus or any of the other
ingredients of this medicine
(listed in section 6).

if you are allergic (hypersensitive) to sirolimus.
IF ANY OF THE ABOVE APPLIES TO YOU, TELL YOUR DOCTOR AND DO NOT TAKE
EVEROLIMUS NOVARTIS.
WARNINGS AND PRECAUTIONS
TALK TO YOUR DOCTOR BEFORE TAKING EVEROLIMUS NOVARTIS:

Medicines that suppress the immune system like Everolimus Novartis
reduce your body´s ability
to fight against infections. It is advisable t

Résumé des caractéristiques du produit

MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_